These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
256 related articles for article (PubMed ID: 18026974)
1. Hypoxic status in ovarian serous and mucinous tumors: relationship between histological characteristics and HIF-1alpha/GLUT-1 expression. Iida T; Yasuda M; Miyazawa M; Fujita M; Osamura RY; Hirasawa T; Muramatsu T; Murakami M; Saito K; Mikami M Arch Gynecol Obstet; 2008 Jun; 277(6):539-46. PubMed ID: 18026974 [TBL] [Abstract][Full Text] [Related]
2. Expression of hypoxia inducible factor-1alpha (HIF-1alpha) and glucose transporter-1 (GLUT-1) in ovarian adenocarcinomas: difference in hypoxic status depending on histological character. Yasuda M; Miyazawa M; Fujita M; Kajiwara H; Iida T; Hirasawa T; Muramatsu T; Murakami M; Mikami M; Saitoh K; Shimizu M; Takekoshi S; Osamura RY Oncol Rep; 2008 Jan; 19(1):111-6. PubMed ID: 18097583 [TBL] [Abstract][Full Text] [Related]
3. Neoangiogenesis and expression of hypoxia-inducible factor 1alpha, vascular endothelial growth factor, and glucose transporter-1 in endometrioid type endometrium adenocarcinomas. Ozbudak IH; Karaveli S; Simsek T; Erdogan G; Pestereli E Gynecol Oncol; 2008 Mar; 108(3):603-8. PubMed ID: 18191183 [TBL] [Abstract][Full Text] [Related]
4. [Relation between the expression of hypoxia inducible factor-1alpha and angiogenesis in ovarian cancer using tissue microarray]. Luo J; Peng ZL; Yang KX; Wang H; Yang H; Dong DD; Yao XY Zhonghua Fu Chan Ke Za Zhi; 2005 Jan; 40(1):38-41. PubMed ID: 15774091 [TBL] [Abstract][Full Text] [Related]
5. Association of hypoxia-inducible factor-1 expression with histology in epithelial ovarian tumors: a quantitative analysis of HIF-1. Miyazawa M; Yasuda M; Fujita M; Hirasawa T; Kajiwara H; Hirabayashi K; Ogane N; Shimizu M; Asanuma H; Murakami M; Takekoshi S; Mikami M; Osamura RY Arch Gynecol Obstet; 2009 Jun; 279(6):789-96. PubMed ID: 18936945 [TBL] [Abstract][Full Text] [Related]
6. The expression and significance of HIF-1alpha and GLUT-3 in glioma. Liu Y; Li YM; Tian RF; Liu WP; Fei Z; Long QF; Wang XA; Zhang X Brain Res; 2009 Dec; 1304():149-54. PubMed ID: 19782666 [TBL] [Abstract][Full Text] [Related]
7. Placental leucine aminopeptidase (P-LAP) and glucose transporter 4 (GLUT4) expression in benign, borderline, and malignant ovarian epithelia. Shibata K; Kajiyama H; Mizokami Y; Ino K; Nomura S; Mizutani S; Terauchi M; Kikkawa F Gynecol Oncol; 2005 Jul; 98(1):11-8. PubMed ID: 15907336 [TBL] [Abstract][Full Text] [Related]
8. [Tissue microarray and in situ hybridization study on hypoxia inducible factor 1alpha mRNA expression in epithelial ovarian tumor]. Luo J; Peng ZL; Wang H; Cheng YF; Yang KX; Xie L; Qian XL; Zou Y Zhonghua Zhong Liu Za Zhi; 2003 Mar; 25(2):168-70. PubMed ID: 12795846 [TBL] [Abstract][Full Text] [Related]
9. [Expression and significance of GLUT-1 and DNA-PKcs in serous ovarian tumors]. Cai Y; Shao SL; Wang QH; Yan LJ; Wang XY; Wang LX Ai Zheng; 2007 Nov; 26(11):1188-93. PubMed ID: 17991316 [TBL] [Abstract][Full Text] [Related]
10. Expression of hypoxia-inducible factor-1 alpha and associated proteins in pancreatic ductal adenocarcinoma and their impact on prognosis. Sun HC; Qiu ZJ; Liu J; Sun J; Jiang T; Huang KJ; Yao M; Huang C Int J Oncol; 2007 Jun; 30(6):1359-67. PubMed ID: 17487356 [TBL] [Abstract][Full Text] [Related]
11. [Expression of hypoxia inducible factor-1alpha and glucose transporter protein 1 in renal and bladder cancers and the clinical significance thereof]. Zhou JT; Cai ZM; Li NC; Na YQ Zhonghua Yi Xue Za Zhi; 2006 Jul; 86(28):1970-4. PubMed ID: 17064593 [TBL] [Abstract][Full Text] [Related]
12. Glucose transporter-1 expression in renal cell carcinoma and its correlation with hypoxia inducible factor-1 alpha. Lidgren A; Bergh A; Grankvist K; Rasmuson T; Ljungberg B BJU Int; 2008 Feb; 101(4):480-4. PubMed ID: 17922867 [TBL] [Abstract][Full Text] [Related]
13. Therapeutic strategy targeting the mTOR-HIF-1alpha-VEGF pathway in ovarian clear cell adenocarcinoma. Miyazawa M; Yasuda M; Fujita M; Kajiwara H; Hirabayashi K; Takekoshi S; Hirasawa T; Murakami M; Ogane N; Kiguchi K; Ishiwata I; Mikami M; Osamura RY Pathol Int; 2009 Jan; 59(1):19-27. PubMed ID: 19121088 [TBL] [Abstract][Full Text] [Related]
14. [Expressions of hypoxia inducible factor-1alpha and insulin-like growth factor-II in gastric carcinoma: correlation with angiogenesis and prognosis]. Ru GQ; Zhao ZS; Tang QL; Xu WJ Zhonghua Wai Ke Za Zhi; 2007 Jul; 45(13):905-8. PubMed ID: 17953839 [TBL] [Abstract][Full Text] [Related]
15. [Expression of hypoxia inducible factor-1α and correlated target genes in human laryngeal carcinoma]. XU O; LI XM; WANG MX; QU YT; LU XY; SHAN CG; SUN QJ Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Apr; 47(4):330-3. PubMed ID: 22800355 [TBL] [Abstract][Full Text] [Related]
16. Coexpression of hypoxia-inducible factor-1α and glucose transporter-1 is associated with poor prognosis in oral squamous cell carcinoma patients. Eckert AW; Lautner MH; Schütze A; Taubert H; Schubert J; Bilkenroth U Histopathology; 2011 Jun; 58(7):1136-47. PubMed ID: 21438910 [TBL] [Abstract][Full Text] [Related]
17. Hypoxia-inducible factor 1 alpha expression increases during colorectal carcinogenesis and tumor progression. Simiantonaki N; Taxeidis M; Jayasinghe C; Kurzik-Dumke U; Kirkpatrick CJ BMC Cancer; 2008 Nov; 8():320. PubMed ID: 18983642 [TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical staining of GLUT1 in benign, borderline, and malignant ovarian epithelia. Kalir T; Wang BY; Goldfischer M; Haber RS; Reder I; Demopoulos R; Cohen CJ; Burstein DE Cancer; 2002 Feb; 94(4):1078-82. PubMed ID: 11920478 [TBL] [Abstract][Full Text] [Related]
19. Aberrant expression of the mammalian target of rapamycin, hypoxia-inducible factor-1α, and glucose transporter 1 in the development of ovarian clear-cell adenocarcinoma. Kato M; Yamamoto S; Takano M; Matsubara O; Furuya K Int J Gynecol Pathol; 2012 May; 31(3):254-63. PubMed ID: 22498943 [TBL] [Abstract][Full Text] [Related]